YKL-40 Inhibits Melanoma Progression and Metastasis by Inducing Immune Cell Infiltration in a Mouse Model

The authors highlight the potential of YKL-40 as a regulator of tumor-immune interactions in melanoma, highlighting its prospective utility in immunotherapy-based treatment strategies for melanoma.